logo en
  • Home
  • Manufacturing
    • Manufacturing
    • OEM Manufacturing
    • Quality Control
  • About the Factory
    • About the Factory
    • Our History
    • Management
    • Certificates
    • Partners
    • Licenses
    • Achievements
    • Special Evaluation of Labour Conditions
    • Videos
  • News
  • Products
  • Contacts
    • Contacts
    • Quality Claims
  • 简体中文(中国)
  • Russian (Russia)

The «Medsintez» plant is a pharmaceutical manufacturer

The company produces infusion solutions, finished dosage forms and API of human insulin and solid and liquid medications. «Medsintez» was one of the first industrial manufacturers of finished dosage forms of genetically engineered human insulin in Russia, who met GMP EC requirements.

Production Facilities

The following production lines are successfully run at the «Medsintez» plant: liquid dosage forms, solid dosage forms, aseptic bottling of recombinant and analogue preparations, recombinant and analogue preparations API by biotechnological synthesis method production, API by chemical synthesis method production.

Read more

OEM Manufacturing

One of the main growth directions for our business is OEM manufacturing or manufacturing products under a customer’s trademark. We partner with leading global manufacturers of pharmaceutical and medical products.

Read more

Finished Products

Since the opening of our plant, more 9 million «Rosinsulin» packages have been produced: solution, suspension and two-phase insulin in bottles, cartridges, pre-filled syringe pens. Drugs are purchased in all regions of the Russian Federation and abroad.

Read more

News

    • PRODUCTION INSTEAD OF IMPORT
      08 / 07 / 2022

      The issue of replacing imported goods with their domestic counterparts is particularly acute for...

    • MEDSINTEZ PLANT – THE BACKBONE OF RUSSIAN PHARMACEUTICAL INDUSTRY!
      06 / 07 / 2022

      The ban on the import of medicines and raw materials for their production into Russia by foreign...

    • More Articles...

Videos

All videos

Pharmacovigilance

«Medsintez» is committed to safety of its products and health of its patients.

Following both ethical principles and requirements of Russian legislation, the company collects and analyses data related to side effects and drug interactions and closely works with regulators in this area. To monitor the effectiveness and safety of their drugs, the company introduced Good EAF Pharmacovigilance Practice.

If you want to report an adverse reaction occurring during the use of a «Medsintez» drug, please contact your doctor.

Also, you can:

Report an adverse reaction via: 

• Fill out the attached form on the site www.drugsafety.ru
• Send information by e-mail: adversereaction@drugsafety.ru 
• Сall the free round-the-clock phone: 8-800-777-8-604
• Send massage via WhatsApp, Viber: +7-903-799-2-186

 

 

 

Quality

The plant has the МС ISO 9001:2015 quality control system in place. The Quality Director's service structure, which includes the quality control and assurance departments, is in full compliance with GMP standards. The core staff was trained at Bayer AG in Leverkusen and Berlin. All plant employees were trained in GMP requirements at special training organizations or at the enterprise itself.

Read more

The «Medsintez» plant was founded in 2003. Today, it is part of the «Ural Biomedical Cluster» Non-Profit Partnership, which comprises more than 20 member companies.

Customer health care is our priority! With any wishes, suggestions, questions or complaints regarding the quality of Medsintez plant products, feel free to contact us by phone
8-800-200-8434 (6:00 to 17:00 Moscow time) or by filling out the electronic form here

Privacy Policy

Copyright © 2003-2023

+7 (34370) 2-50-61

+7 (34370) 2-54-95

Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130

Contacts